CEUEX
Price
$60.53
Change
+$0.40 (+0.67%)
Updated
Jul 31 closing price
Net Assets
140.66B
CIESX
Price
$29.76
Change
-$0.27 (-0.90%)
Updated
Jul 31 closing price
Net Assets
835.36M
Interact to see
Advertisement

CEUEX vs CIESX

CEUEX vs CIESX Comparison Chart in %
View a ticker or compare two or three
VS
CEUEX vs. CIESX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CEUEX is a Buy and CIESX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CEUEX has more cash in the bank: 141B vs. CIESX (835M). CEUEX pays higher dividends than CIESX: CEUEX (2.46) vs CIESX (1.14). CEUEX was incepted earlier than CIESX: CEUEX (24 years) vs CIESX (7 years). CEUEX (1.09) is less costly to investors than CIESX (0.88). CEUEX is a more actively managed with annual turnover of: 50.00 vs. CIESX (29.00). CEUEX has a lower initial minimum investment than CIESX: CEUEX (250) vs CIESX (5000000). CIESX annual gain was more profitable for investors over the last year : 16.37 vs. CEUEX (7.49). CIESX return over 5 years is better than : 15.52 vs. CEUEX (-4.16).
CEUEXCIESXCEUEX / CIESX
Total Expense Ratio1.090.85128%
Annual Report Gross Expense Ratio1.090.88124%
Fund Existence24 years7 years-
Gain YTD3.54110.50934%
Front LoadN/AN/A-
Min. Initial Investment25050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets141B835M16,886%
Annual Yield % from dividends2.461.14216%
Returns for 1 year7.4916.3746%
Returns for 3 years16.7230.6255%
Returns for 5 years-4.1615.52-27%
Returns for 10 years49.35N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SLGYX23.050.19
+0.83%
Saratoga Large Capitalization Growth A
JHAAX10.710.01
+0.09%
JHancock Multi-Asset Absolute Return A
PCGRX28.71-0.07
-0.24%
Victory Pioneer Mid Cap Value A
ECASX25.03-0.16
-0.64%
Eaton Vance Atlanta Capital SMID-Cap C
FBTIX49.83-1.21
-2.37%
Fidelity Advisor Biotechnology I